GLOBIVAC ND UNIQUE

Dosage

Children: Refer to specific medications used to treat the particular disease for dosing information.

Adults: Refer to specific medications used to treat the particular disease for dosing information.

Mechanism of action

The mechanism of action varies significantly depending on the specific disease in question. For infectious diseases, pathogens may interact with host cells, leading to inflammation, immune response activation, or tissue damage. Chronic diseases often involve complex interactions between genetic factors, lifestyle choices, and environmental influences. For example, in autoimmune diseases, the immune system mistakenly targets healthy cells, leading to inflammation and tissue destruction.

Pharmacodynamics

Pharmacodynamics of disease involves understanding how the disease state affects physiological functions and the body's response to treatment. In infectious diseases, the presence of pathogens can lead to altered immune responses, while chronic diseases may involve changes in metabolic pathways, hormonal balances, or cellular functions. Medications targeting disease processes aim to restore normal function, alleviate symptoms, or eradicate pathogens.

Pharmacokinetics

Pharmacokinetics is not applicable to the term 'disease' as it refers to the movement of drugs within the body, including absorption, distribution, metabolism, and excretion of specific medications used to treat diseases. Each medication will have its own pharmacokinetic profile depending on its chemical properties and the disease being treated.

Indications

• Nutritional supplementation
• Herbal therapy for various conditions
• Preservation of medicinal properties of plants

Dosage

Children: Dosage for dried herbal preparations in children should be approached cautiously and is best determined by a healthcare professional. Refer to paediatric guidelines for specific dosing recommendations.

Adults: Dosage for dried herbal preparations varies widely depending on the specific herb and its intended use. Refer to specific guidelines or reputable sources for dosing information.

Mechanism of action

The mechanism of action for dried herbal preparations varies depending on the specific plant material involved. Generally, the active constituents in dried herbs can exert their effects through various pathways, such as modulating neurotransmitter systems, influencing metabolic pathways, and acting on specific receptors in the body. For instance, flavonoids, terpenes, and alkaloids found in certain dried herbs can exhibit anti-inflammatory, antioxidant, or antimicrobial properties.

Pharmacodynamics

The pharmacodynamics of dried drugs depend on their specific chemical constituents. These compounds can affect physiological functions, such as modulating inflammatory responses, enhancing immune function, or affecting neurotransmission. The effects can vary widely based on the type of herb, the method of drying, and the concentration of active ingredients.

Pharmacokinetics

The pharmacokinetics of dried herbal preparations can vary significantly based on the specific herb used. Generally, after ingestion, the active compounds are absorbed in the gastrointestinal tract, metabolized primarily by the liver, and then excreted through urine or feces. The bioavailability of these compounds can be influenced by factors such as the form of the preparation (e.g., powder, extract), the presence of other food substances, and individual patient characteristics.

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Local anesthesia of mucous membranes
• Topical anesthesia in oral and nasal procedures
• Laryngeal anesthesia

Dosage

Children: Refer to the BNF for Children for appropriate paediatric dosing, as it is based on age and weight.

Adults: Refer to the BNF for specific dosing guidance as it varies by indication and clinical scenario.

Mechanism of action

Cocaine produces anesthesia by reversibly binding to and inactivating sodium channels, which are essential for the depolarization and impulse propagation along nerve cells. Additionally, cocaine's blockade of norepinephrine reuptake leads to its vasoconstrictive effects. The drug also prevents the re-uptake of dopamine, serotonin, and norepinephrine into pre-synaptic neurons, influencing neurotransmitter levels.

Pharmacodynamics

Cocaine is primarily indicated for the introduction of local anesthesia in accessible mucous membranes, including those of the oral, laryngeal, and nasal cavities. Its rapid onset of action and potent local anesthetic properties make it effective for short procedures requiring localized pain relief.

Pharmacokinetics

Cocaine is absorbed quickly through mucous membranes and has a short duration of action. It undergoes extensive hepatic metabolism, primarily by enzymes such as CYP3A4 and CYP2D6, producing metabolites that are then excreted in urine. The onset of anesthesia typically occurs within minutes, while the effects can last from 30 minutes to several hours, depending on the route of administration and dosage.

Contra-indications

• Hypersensitivity to cocaine or any of its components
• Severe hypertension
• Severe coronary artery disease
• History of arrhythmias

Adverse effects

• Cardiovascular disturbances (e.g., hypertension, tachycardia)
• CNS effects (e.g., anxiety, agitation, seizures)
• Local tissue necrosis at the injection site
• Allergic reactions (e.g., rash, anaphylaxis)

Interactions

• Monoamine oxidase inhibitors (MAOIs) may enhance the effects of cocaine
• Other sympathomimetic drugs can increase cardiovascular effects
• Alcohol may potentiate the CNS effects of cocaine

Precautions

• Use with caution in patients with a history of substance abuse
• Monitor blood pressure and heart rate during administration
• Avoid use in patients with significant hepatic impairment
• Consider potential for addiction and abuse

Pregnancy

Cocaine is contraindicated during pregnancy due to potential harm to the fetus, including risk of miscarriage, premature birth, and developmental issues.

Breast-feeding

Cocaine is excreted in breast milk and may pose a risk to nursing infants; breastfeeding should be avoided during and after use.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Topical solution for mucous membrane application
• Injection solution for local anesthesia

Indications

• Vaccination against Newcastle disease in poultry
• Prevention of respiratory disease in avian species

Dosage

Children: Refer to specific veterinary guidelines and product information for dosing.

Adults: Refer to specific veterinary guidelines and product information for dosing.

Mechanism of action

Lentogenic viruses act by infecting host cells and inducing an immune response. They utilize the host cell machinery for replication and can stimulate both humoral and cellular immunity. The immune response generated helps protect against virulent strains of the virus by producing specific antibodies and activating T-cells.

Pharmacodynamics

The pharmacodynamics of lentogenic vaccines involve the activation of the immune system upon exposure to the attenuated virus. This leads to the production of antibodies and the enhancement of T-cell responses, which provide active immunity against Newcastle disease. The immune response typically peaks several weeks after vaccination, providing long-lasting protection.

Pharmacokinetics

As live attenuated vaccines, lentogenic strains are administered via injection or orally. The pharmacokinetics of these vaccines involve replication at the site of administration, followed by dissemination to lymphoid tissues where immune responses are initiated. The duration of immunity varies, but generally lasts for several months to years, depending on the specific strain and the health of the vaccinated individual.

Pregnancy

Lentogenic strains are generally considered safe in pregnancy, but specific recommendations should be consulted based on the strain and context of use.

Breast-feeding

Safety during breastfeeding is not well established; consult a healthcare provider for advice.

Storage

Store at a controlled room temperature, away from light and moisture. Specific storage conditions may depend on the formulation and manufacturer instructions.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Prevention of Newcastle disease in poultry
• Management of respiratory infections in birds

Dosage

Children: Refer to the manufacturer's guidelines for specific dosage recommendations, as dosing may vary based on developmental stages of the avian species.

Adults: Refer to the manufacturer's guidelines for specific dosage recommendations based on the formulation and age of poultry.

Mechanism of action

The active ingredients in Ranikhet, such as live attenuated vaccines, work by stimulating the immune response in birds. These vaccines induce the formation of antibodies and cellular immunity, protecting the birds from specific viral infections, particularly Newcastle disease.

Pharmacodynamics

Ranikhet enhances the immune response of chickens against Newcastle disease virus. The immune system recognizes the attenuated virus in the vaccine, which leads to the production of antibodies. This process helps in preventing the disease and reducing the severity of infections if they occur.

Pharmacokinetics

The pharmacokinetics of Ranikhet in poultry involves the absorption of the vaccine components after administration. The onset of immunity typically occurs within a few weeks, with peak antibody levels reached at about 4 to 6 weeks post-vaccination. The duration of immunity can vary, typically lasting several months, depending on the specific strain used.

Pregnancy

Ranikhet is not typically used in pregnant individuals; consult a healthcare provider for advice.

Breast-feeding

Consult a healthcare provider before use during breastfeeding, as safety data is limited.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Bronchospasm
• Exercise-Induced Bronchoconstriction

Dosage

Children: Refer to the BNF for Children for dosing guidance tailored to pediatric patients.

Adults: Refer to the BNF for specific adult dosing recommendations based on the condition being treated.

Mechanism of action

Tanuvas acts by inhibiting the action of phosphodiesterase, leading to an increase in intracellular cyclic AMP levels. This results in relaxation of bronchial smooth muscle, thereby dilating the airways. Additionally, it has anti-inflammatory properties that help in reducing airway inflammation, which is crucial in the management of asthma and COPD.

Pharmacodynamics

The pharmacodynamics of Tanuvas involve its effects on the respiratory system, leading to bronchodilation and improved airflow. Its anti-inflammatory action helps to reduce the frequency and severity of asthma attacks and exacerbations in COPD. The onset of action is typically rapid, providing relief from acute bronchospasm and contributing to better control of chronic respiratory conditions.

Pharmacokinetics

Tanuvas is well absorbed following administration, with peak plasma concentrations occurring within a few hours. It undergoes hepatic metabolism, primarily via cytochrome P450 enzymes, and is excreted through urine and feces. The elimination half-life varies depending on the specific formulation and patient factors, but it generally allows for once or twice daily dosing to maintain therapeutic levels.

Contra-indications

• Hypersensitivity to tanuvas or any of its components
• Severe hepatic impairment
• Pregnancy

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Dizziness
• Fatigue
• Rash
• Altered liver function tests

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• Potential interaction with other hepatotoxic drugs
• Caution with other medications metabolized by the liver

Precautions

• Use with caution in patients with pre-existing liver disease
• Monitor liver function tests regularly
• Assess for signs of hypersensitivity reactions

Pregnancy

Tanuvas is contraindicated in pregnancy due to potential risks to the fetus.

Breast-feeding

It is not known whether tanuvas is excreted in human milk. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablet
• Injectable solution

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, hepatitis B, influenza, and human papillomavirus (HPV)
• Travel vaccinations for diseases endemic to certain regions
• Vaccination for at-risk populations, such as those with compromised immune systems or specific occupational exposures

Dosage

Children: Dosage varies by vaccine type and age; refer to the BNF for Children for specific dosing information.

Adults: Dosage varies by vaccine type and indication; refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by mimicking an infection. They introduce a harmless component of a pathogen (antigen) to the immune system, prompting the body to produce an immune response. This includes the generation of antibodies and memory cells that provide long-term immunity. Upon subsequent exposure to the actual pathogen, the immune system is primed to respond more rapidly and effectively.

Pharmacodynamics

The pharmacodynamics of vaccines involves the activation of both humoral and cellular immunity. Vaccines stimulate B cells to produce antibodies against the pathogen, while T cells are activated to destroy infected cells. This dual response helps to establish immunological memory, which enables a faster and more robust response upon re-exposure to the pathogen.

Pharmacokinetics

Vaccines are administered via various routes, including intramuscular, subcutaneous, and oral. After administration, the antigens are presented to antigen-presenting cells, which activate T cells and stimulate B cell proliferation and differentiation. The half-life of vaccine-induced immunity varies depending on the type of vaccine, with some providing lifelong immunity and others requiring booster doses to maintain protection.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Severe immunocompromised state for live attenuated vaccines

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Nausea

Interactions

• Immunosuppressive medications may reduce vaccine efficacy
• Concurrent administration of some vaccines may require spacing to optimize immune response

Precautions

• History of allergic reactions to vaccines or vaccine components
• Pregnancy (specific vaccines may be contraindicated)
• Moderate to severe acute illness with or without fever

Pregnancy

Consult healthcare provider. Some vaccines are contraindicated during pregnancy, while others are recommended.

Breast-feeding

Generally considered safe, but consult healthcare provider regarding specific vaccines.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Liquid suspension for injection
• Lyophilized powder for reconstitution

Mechanism of action

Cocaine produces anesthesia by inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. This is achieved by reversibly binding to and inactivating sodium channels. Sodium influx through these channels is necessary for the depolarization of nerve cell membranes and subsequent propagation of impulses along the course of the nerve. Cocaine is the only local anesthetic with vasoconstrictive properties. This is a result of its blockade of norepinephrine reuptake in the autonomic nervous system. Cocaine binds differentially to the dopamine, serotonin, and norepinephrine transport proteins and directly prevents the re-uptake of dopamine, serotonin, and norepinephrine into pre-synaptic neurons. Its effect on dopamine levels is most responsible for the addictive property of cocaine. The presence and function of cannabinoid CB(2) receptors in the brain have been the subjects of much debate. /The investigators/ found that systemic, intranasal or intra-accumbens local administration of JWH133, a selective CB(2) receptor agonist, dose-dependently inhibited intravenous cocaine self-administration, cocaine-enhanced locomotion, and cocaine-enhanced accumbens extracellular dopamine in wild-type and CB(1) receptor knockout (CB(1)(-/-), also known as Cnr1(-/-)) mice, but not in CB(2)(-/-) (Cnr2(-/-)) mice. This inhibition was mimicked by GW405833, another CB(2) receptor agonist with a different chemical structure, and was blocked by AM630, a selective CB(2) receptor antagonist. Intra-accumbens administration of JWH133 alone dose-dependently decreased, whereas intra-accumbens administration of AM630 elevated, extracellular dopamine and locomotion in wild-type and CB(1)(-/-) mice, but not in CB(2)(-/-) mice. Intra-accumbens administration of AM630 also blocked the reduction in cocaine self-administration and extracellular dopamine produced by systemic administration of JWH133. These findings suggest that brain CB(2) receptors modulate cocaine's rewarding and locomotor-stimulating effects, likely by a dopamine-dependent mechanism. Cocaine hydrochloride is a local anesthetic which blocks initiation or conduction of nerve impulses following local application; when applied topically to mucous membranes, the drug also produces intense vasoconstriction. When applied topically to the mucous membranes of the nose or mouth, cocaine reduces the acuity of smell or taste, respectively. Cocaine exerts an indirect adrenergic effect by interfering with the uptake of norepinephrine by adrenergic nerve terminals, and therefore potentiates the effects of catecholamines. The indirect adrenergic effect is apparently the mechanism by which the drug produces vasoconstriction and mydriasis. Cocaine has CNS stimulating effects. The drug is also markedly pyrogenic, augmenting heat production by stimulating muscular activity and decreasing heat loss through vasoconstriction. Cocaine has multiple central and peripheral pharmacological actions. The action responsible for the rewarding property, and hence the abuse liability, of cocaine is an action in the dopaminergic synapse; in the rat the major set of critical dopaminergic synapses appears to be in the nucleus accumbens. Cocaine prolongs the activity of dopamine in the synapse by blocking the dopamine reuptake mechanism (which usually inactivates the transmitter by removing it from the proximity of its synaptic targets). This is an action shared with amphetamine; in addition to blocking the dopamine reuptake mechanism, amphetamine also augments dopaminergic function by augmenting dopamine release directly into the synapse. While amphetamine and cocaine have discriminable subjective effects, perhaps due to differences in rate of onset and metabolism or perhaps due to different side effects, cocaine shares its rewarding impact and abuse liability very closely with amphetamine. When drug access is unlimited, cocaine and amphetamine have the same ability to dominate behavior, reducing other beha

Pharmacodynamics

Cocaine is a local anesthetic indicated for the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.